Publications (4 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Anti‑CXCR4 chemokine receptor, motixafortide, as an adjunct treatment with anti‑TB drugs decreases the bacterial burden by improving drug distribution
- https://www.spandidos-publications.com/10.3892/wasj.2023.190
- KS Davuluri, AK Singh, AV Singh… - World Academy of …, 2023 - spandidos-publications.com
- CXC motif chemokine receptor 4 (CXCR4) is involved in the migration of bloodcells and the formation of blood vessels. It is expressed on blood cells and other immune cells such as …
* Davuluri KS et al. (2023) Anti CXCR4 chemokine receptor, motixafortide, as an adjunct treatment with anti?TB drugs decreases the bacterial burden by improving drug distribution. WORLD ACADEMY OF SCIENCES JOURNAL 5(13):1-12.
* Davuluri KS et al. (2022) Stimulated expression of ELR+ chemokines, VEGFA and TNF-AIP3 promote mycobacterial dissemination in extrapulmonary tuberculosis patients and Cavia porcellus model of tuberculosis. Tuberculosis (Edinb). 135:102224.